Synergistic action of clotrimazole and sulfamethoxazole on Candida albicans and related species

W. H. Beggs, george a sarosi, N. M. Steele

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

The antifungal drug clotrimazole (CTM) has an uncertain future with respect to treatment of the systemic mycoses. To explore further the chemotherapeutic potential of this drug, the authors have been studying in vitro effects of low level CTM in combination with other drugs against Candida species. Results with CTM and sulfamethoxazole (SMX) are presented here. A subinhibitory concentration of SMX (50 μg./ml.) in combination with a weak inhibitory level of CTM (1.0 μg./ml.) exerted marked fungistatic effects on 4 different strains of Candida albicans. Combined activity exceeded that of CTM alone and was interpreted as drug synergism. Similar results were obtained with strains of Candida tropicalis and Candida parapsilosis.

Original languageEnglish (US)
Pages (from-to)623-629
Number of pages7
JournalCurrent Therapeutic Research - Clinical and Experimental
Volume20
Issue number4 II
StatePublished - Jan 1 1976
Externally publishedYes

Fingerprint Dive into the research topics of 'Synergistic action of clotrimazole and sulfamethoxazole on Candida albicans and related species'. Together they form a unique fingerprint.

Cite this